<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · SK Biopharmaceuticals</title><link>https://yestino.com/zh-CN/entities/sk-biopharmaceuticals-f729e5</link><description>与 SK Biopharmaceuticals 相关的全部事件</description><language>zh-CN</language><atom:link href="https://yestino.com/zh-CN/entities/sk-biopharmaceuticals-f729e5/feed.xml" rel="self" type="application/rss+xml"/><item><title>Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal</title><link>https://yestino.com/zh-CN/events/biohaven-shares-climb-7-after-signing-major-sk-biopharmaceut-837fbc</link><guid isPermaLink="true">https://yestino.com/zh-CN/events/biohaven-shares-climb-7-after-signing-major-sk-biopharmaceut-837fbc</guid><pubDate>Wed, 26 Aug 2026 12:28:24 GMT</pubDate><description>来源：Yahoo Finance</description></item></channel></rss>